← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Synactix Pharmaceuticals, Inc.
Tucson, AZ
$639,950
Total funding
2
Grants
Funding over time
peak $300K · FY2015–18$500K$375K$250K$125K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$639,950 · 2
By mechanism
R41$639,950 · 2
Investigators at Synactix Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Pre-IND Study of Pz-1, a dual pan-RET/VEGFR2 inhibitor for the Treatment of RET-driven Disease$299,975
R41 · FY2015 · CA
Preclinical studies of Selective and Orally Bioavailable Aurora B Inhibitors for the Treatment of AML$299,975
R41 · FY2018 · CA
Synactix Pharmaceuticals I-Corps Application$40,000
R41 · FY2016 · CA